{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:05:32Z","timestamp":1790399132916,"version":"4.1.0"},"reference-count":36,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2011.0732","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:20:20Z","timestamp":1525252820000},"source":"Crossref","is-referenced-by-count":14,"title":["The Treatment of Chronic Graft-Versus-Host Disease"],"prefix":"10.3238","author":[{"given":"Daniel","family":"Wolff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Greinix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Lawitschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Halter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Holler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2011,10,28]]},"reference":[{"key":"10.3238\/arztebl.2011.0732_ref1","doi-asserted-by":"crossref","unstructured":"Akpek G, Zahurak ML, Piantadosi S, et al.: Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219\u201326.","DOI":"10.1182\/blood.V97.5.1219"},{"key":"10.3238\/arztebl.2011.0732_ref2","doi-asserted-by":"crossref","unstructured":"Lee SJ, Klein JP, Barrett AJ, et al.: Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002;100: 406\u201314.","DOI":"10.1182\/blood.V100.2.406"},{"key":"10.3238\/arztebl.2011.0732_ref3","doi-asserted-by":"crossref","unstructured":"Lee SJ, Vogelsang G, Flowers ME: Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215\u201333.","DOI":"10.1053\/bbmt.2003.50026"},{"key":"10.3238\/arztebl.2011.0732_ref4","doi-asserted-by":"crossref","unstructured":"Ferrara JL, Levine JE, Reddy P, Holler E: Graft-versus-host disease. Lancet 2009; 373: 1550\u201361.","DOI":"10.1016\/S0140-6736(09)60237-3"},{"key":"10.3238\/arztebl.2011.0732_ref5","doi-asserted-by":"crossref","unstructured":"Couriel D: Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant 2006; 12: 375\u201396.","DOI":"10.1016\/j.bbmt.2006.02.003"},{"key":"10.3238\/arztebl.2011.0732_ref6","doi-asserted-by":"crossref","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, et al.: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945\u201356.","DOI":"10.1016\/j.bbmt.2005.10.001"},{"key":"10.3238\/arztebl.2011.0732_ref7","doi-asserted-by":"crossref","unstructured":"Greinix HT: Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Biol Blood Marrow Transplant 2011; 17: 167\u201375.","DOI":"10.1016\/j.bbmt.2010.07.017"},{"key":"10.3238\/arztebl.2011.0732_ref8","doi-asserted-by":"crossref","unstructured":"Wolff D: Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. Biol Blood Marrow Transplant 2010; 16: 1611\u201328.","DOI":"10.1016\/j.bbmt.2010.06.015"},{"key":"10.3238\/arztebl.2011.0732_ref9","doi-asserted-by":"crossref","unstructured":"Martin PJ, Storer BE, Rowley SD, et al.: Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease. Blood 2009; 113: 5074\u201382.","DOI":"10.1182\/blood-2009-02-202937"},{"key":"10.3238\/arztebl.2011.0732_ref10","doi-asserted-by":"crossref","unstructured":"Wolff D, Schleuning M, von Harsdorf S, et al.: Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2011; 17: 1\u201317.","DOI":"10.1016\/j.bbmt.2010.05.011"},{"key":"10.3238\/arztebl.2011.0732_ref11","doi-asserted-by":"crossref","unstructured":"Podzamczer D, Salazar A, Jimenez J, et al.: Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995; 122: 755\u201361.","DOI":"10.7326\/0003-4819-122-10-199505150-00004"},{"key":"10.3238\/arztebl.2011.0732_ref12","doi-asserted-by":"crossref","unstructured":"Erard V, Wald A, Corey L, Leisenring WM, Boeckh M: Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. J Infect Dis 2007; 196: 266\u201370.","DOI":"10.1086\/518938"},{"key":"10.3238\/arztebl.2011.0732_ref13","doi-asserted-by":"crossref","unstructured":"Ljungman P, Cordonnier C, Einsele H, et al.: Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521\u20136.","DOI":"10.1038\/bmt.2009.263"},{"key":"10.3238\/arztebl.2011.0732_ref14","doi-asserted-by":"crossref","unstructured":"Hilgendorf I: Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. Vaccine 2011; 29: 2825\u201333.","DOI":"10.1016\/j.vaccine.2011.02.018"},{"key":"10.3238\/arztebl.2011.0732_ref15","doi-asserted-by":"crossref","unstructured":"Tauchmanova L, Selleri C, De RG, et al.: Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review. Menopause 2007; 14: 320\u201330.","DOI":"10.1097\/01.gme.0000232032.84788.8c"},{"key":"10.3238\/arztebl.2011.0732_ref16","doi-asserted-by":"crossref","unstructured":"Tauchmanova L, Colao A, Lombardi G, Rotoli B, Selleri C: Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. J Clin Endocrinol Metab 2007; 92: 4536\u201345.","DOI":"10.1210\/jc.2006-2870"},{"key":"10.3238\/arztebl.2011.0732_ref17","doi-asserted-by":"crossref","unstructured":"Hautmann AH, Elad S, Lawitschka A, et al.: Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic GVHD. Transpl Int 2011; DOI: 10.1111\/j.1432\u20132277.2011.01264.x (epub ahead of print).","DOI":"10.1111\/j.1432-2277.2011.01264.x"},{"key":"10.3238\/arztebl.2011.0732_ref18","doi-asserted-by":"crossref","unstructured":"Chiodi S, Spinelli S, Ravera G, et al.: Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614\u20139.","DOI":"10.1046\/j.1365-2141.2000.02053.x"},{"key":"10.3238\/arztebl.2011.0732_ref19","doi-asserted-by":"crossref","unstructured":"Fraser CJ, Bhatia S, Ness K, et al.: Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 2006; 108: 2867\u201373.","DOI":"10.1182\/blood-2006-02-003954"},{"key":"10.3238\/arztebl.2011.0732_ref20","doi-asserted-by":"crossref","unstructured":"Herzberg PY, Heussner P, Mumm FH, et al.: Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 1707\u201317.","DOI":"10.1016\/j.bbmt.2010.05.018"},{"key":"10.3238\/arztebl.2011.0732_ref21","doi-asserted-by":"crossref","unstructured":"Wiskemann J, Huber G: Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 321\u20139.","DOI":"10.1038\/sj.bmt.1705917"},{"key":"10.3238\/arztebl.2011.0732_ref22","doi-asserted-by":"crossref","unstructured":"Li L, Chan L, Gerber LH: Rehabilitation evaluation and treatment of patients with chronic graft-versus-host disease. In: Vogelsang GB, Pavletic SZ (eds.): Chronic Graft-verus-Host Disease. New York: Cambridge University Press, 2009: 252\u201367.","DOI":"10.1017\/CBO9780511576751.025"},{"key":"10.3238\/arztebl.2011.0732_ref23","doi-asserted-by":"crossref","unstructured":"Zecca M, Prete A, Rondelli R, et al.: Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192\u2013200.","DOI":"10.1182\/blood-2001-11-0059"},{"key":"10.3238\/arztebl.2011.0732_ref24","doi-asserted-by":"crossref","unstructured":"Baird K, Wayne AS, Jacobsohn DA: Pediatric chronic graft-versus-host disease. In: Vogelsang GB, Pavletic SZ (eds.): chronic graft versus host disease. New York: Cambridge University Press, 2009: 369\u201385. \/td>","DOI":"10.1017\/CBO9780511576751.034"},{"key":"10.3238\/arztebl.2011.0732_ref25","doi-asserted-by":"crossref","unstructured":"Gratwohl A: The EBMT activity survey 2008: impact of team size, team density and new trends. Bone Marrow Transplant 2011; 46: 174\u201391.","DOI":"10.1038\/bmt.2010.69"},{"key":"10.3238\/arztebl.2011.0732_ref26","doi-asserted-by":"crossref","unstructured":"Grauer O, Wolff D, Bertz H, et al.: Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 2010; 133: 2852\u201365.","DOI":"10.1093\/brain\/awq245"},{"key":"10.3238\/arztebl.2011.0732_ref27","doi-asserted-by":"crossref","unstructured":"Travnik R, Beckers M, Wolff D, Holler E, Landthaler M, Karrer S: Graft-versus-Host Disease (GvHD)\u2014an update: Part 1: Pathophysiology, clinical features and classification of GvHD. Hautarzt 2011; 62: 139\u201355.","DOI":"10.1007\/s00105-010-2107-4"},{"key":"10.3238\/arztebl.2011.0732_ref28","unstructured":"Dietrich T, Cursiefen C, Westekemper H, et al.: Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): Diagnosis and treatment of ocular chronic GVHD. Cornea 2011; in press."},{"key":"10.3238\/arztebl.2011.0732_ref29","doi-asserted-by":"crossref","unstructured":"Meier JK, Wolff D, Pavletic S, et al.: Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clin Oral Invest 2011; 15: 127\u201339.","DOI":"10.1007\/s00784-010-0450-6"},{"key":"10.3238\/arztebl.2011.0732_ref30","doi-asserted-by":"crossref","unstructured":"Tomas JF, Pinilla I, Garcia-Buey ML, et al.: Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000; 26: 649\u201355.","DOI":"10.1038\/sj.bmt.1702532"},{"key":"10.3238\/arztebl.2011.0732_ref31","doi-asserted-by":"crossref","unstructured":"Akpek G, Boitnott JK, Lee LA, et al.: Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002; 100: 3903\u20137.","DOI":"10.1182\/blood-2002-03-0857"},{"key":"10.3238\/arztebl.2011.0732_ref32","doi-asserted-by":"crossref","unstructured":"Akpek G, Chinratanalab W, Lee LA, et al.: Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 2003; 9: 46\u201351.","DOI":"10.1053\/bbmt.2003.49999"},{"key":"10.3238\/arztebl.2011.0732_ref33","unstructured":"Spinelli S, Chiodi S, Costantini S, et al.: Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. Haematologica 2003; 88: 1163\u20138."},{"key":"10.3238\/arztebl.2011.0732_ref34","doi-asserted-by":"crossref","unstructured":"Hildebrandt C, Fazekas T, Lawitschka A, et al.: Diagnosis and treatment of pulmonary chronic graft-versus-host disease: report from the International Consensus Conference on Clinical Practice in chronic GVHD. Bone Marrow Transplantation 2011; (epub ahead of print)","DOI":"10.1038\/bmt.2011.35"},{"key":"10.3238\/arztebl.2011.0732_ref35","doi-asserted-by":"crossref","unstructured":"Beredjiklian PK, Drummond DS, Dormans JP, Davidson RS, Brock GT, August C: Orthopaedic manifestations of chronic graft-versus-host disease. J Pediatr Orthop 1998; 18: 572\u20135.","DOI":"10.1097\/01241398-199809000-00002"},{"key":"10.3238\/arztebl.2011.0732_ref36","doi-asserted-by":"crossref","unstructured":"Marks C, Stadler M, H\u00e4usermann P, et al.: German-Austrian-Swiss Consensus conference on clinical practice in chronic GVHD: guidance for supportive therapy of chronic cutaneous and musculoskeletal graft-versus-host disease. Br J Dermatol 2011; 165: 18\u201329.","DOI":"10.1111\/j.1365-2133.2011.10360.x"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T15:02:36Z","timestamp":1638802956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2011.0732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,28]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2011.0732","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,28]]}}}